Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Numao

Showing results (381-390 of 419) with videos related to

Pageof 42
Sort By:
Clinical Genitourinary Cancer|January 28, 2025
Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study)Yuki Nakamura, Hajime Tanaka, Noboru Numao, et al.
Japanese Circulation Journal|November 1, 1996
Angiographic and coronary risk factor analyses of Japanese patients with ischemic heart disease before age 40--a multicenter cooperative studyK Ogawa, T Numao, M Iizuka, et al.
Japanese Circulation Journal|October 10, 1998
Changes of ischemic heart disease in Utsunomiya, Japan, over 10 years: a survey of primary care physiciansA Sakurai, S Oka, J Sekine, et al.
International Journal of Clinical Oncology|April 21, 2025
Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)Kenji Tanabe, Soichiro Yoshida, Tomoki Kimura, et al.
International Journal of Clinical Oncology|June 4, 2024
Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA studyKenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 4, 2025
Real-World Outcomes of First-Line Systematic Treatment in Locally Advanced or Metastatic Upper Urinary Tract Urothelial Carcinoma With Renal Impairment (YUSHIMA Study)Tomoki Kimura, Motohiro Fujiwara, Yuya Maezawa, et al.
Physical Review Letters|February 26, 1996
Search for the decay K+--> pi + nu nu -barAdler, Atiya, Chiang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 23, 2017
Predictors of International Normalized Ratio Variability in Patients With Atrial Fibrillation Under Warfarin TherapyYoshimi Numao, Shinya Suzuki, Takuto Arita, et al.
Cancer Medicine|September 5, 2020
Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary studyHiroshi Fukushima, Toshiki Kijima, Shohei Fukuda, et al.
Liver Cancer|August 18, 2022
Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential TherapyHidekatsu Kuroda, Takayoshi Oikawa, Masashi Ninomiya, et al.
Pageof 42

Showing results (381-390 of 419) with videos related to

Sort By:
Pageof 42
Clinical Genitourinary Cancer|January 28, 2025
Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Comprehensive Treatment Outcomes and Prognostic Insights From a Multicenter Real-World Study (YUSHIMA Study)Yuki Nakamura, Hajime Tanaka, Noboru Numao, et al.
Japanese Circulation Journal|November 1, 1996
Angiographic and coronary risk factor analyses of Japanese patients with ischemic heart disease before age 40--a multicenter cooperative studyK Ogawa, T Numao, M Iizuka, et al.
Japanese Circulation Journal|October 10, 1998
Changes of ischemic heart disease in Utsunomiya, Japan, over 10 years: a survey of primary care physiciansA Sakurai, S Oka, J Sekine, et al.
International Journal of Clinical Oncology|April 21, 2025
Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)Kenji Tanabe, Soichiro Yoshida, Tomoki Kimura, et al.
International Journal of Clinical Oncology|June 4, 2024
Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA studyKenji Tanabe, Shuichiro Kobayashi, Yuya Maezawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 4, 2025
Real-World Outcomes of First-Line Systematic Treatment in Locally Advanced or Metastatic Upper Urinary Tract Urothelial Carcinoma With Renal Impairment (YUSHIMA Study)Tomoki Kimura, Motohiro Fujiwara, Yuya Maezawa, et al.
Physical Review Letters|February 26, 1996
Search for the decay K+--> pi + nu nu -barAdler, Atiya, Chiang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 23, 2017
Predictors of International Normalized Ratio Variability in Patients With Atrial Fibrillation Under Warfarin TherapyYoshimi Numao, Shinya Suzuki, Takuto Arita, et al.
Cancer Medicine|September 5, 2020
Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary studyHiroshi Fukushima, Toshiki Kijima, Shohei Fukuda, et al.
Liver Cancer|August 18, 2022
Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential TherapyHidekatsu Kuroda, Takayoshi Oikawa, Masashi Ninomiya, et al.
Pageof 42